Nanoimmunotherapy: Application of nanotechnology for sustained and targeted delivery of antigens to dendritic cells

Nanomedicine

Volumn 7, Issue 1, 2012, Pages 1-4

  Zhang, Zhiping ^a   Guo, Yajun ^b   Feng, Si Shen ^c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

antigen delivery; cancer nanotechnology; dendritic cells; immune response; nanobiotechnology; nanocarriers

Indexed keywords

ALUMINUM SALT; ANTIGEN; COMPLEMENTARY DNA; DECTIN 1; DECTIN 2; EPITOPE; FREUND ADJUVANT; NANOCARRIER; POLYGLACTIN; TOLL LIKE RECEPTOR; TUMOR ANTIGEN;

ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; CANCER IMMUNIZATION; CELL CULTURE; CELL ISOLATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; IMMUNOTHERAPY; LYMPH NODE; NANOTECHNOLOGY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TUMOR IMMUNITY;

ANTIGENIC MODULATION; ANTIGENS; DENDRITIC CELLS; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNITY, CELLULAR; IMMUNOTHERAPY; LECTINS, C-TYPE; NANOPARTICLES; NANOTECHNOLOGY; T-LYMPHOCYTES, CYTOTOXIC; TUMOR ESCAPE;

EID: 84555202701     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.171     Document Type: Review

References (18)

1. Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: moving beyond current vaccines. Nat. Med. 10, 909-915 (2004). (Pubitemid 39273730)
2. Krishnamachari Y, Geary SM, Lemke CD, Salem AK. Nanoparticle delivery systems in cancer vaccines. Pharm. Res. 28, 215-236 (2011).
3. Hamdy S, Haddadi A, Ghotbi Z, Hung RW, Lavasanifar A. Part I: targeted particles for cancer immunotherapy. Curr. Drug Deliv. 8, 261-273 (2011).
4. Bal SM, Hortensius S, Ding Z, Jiskoot W, Bouwstra JA. Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination. Vaccine 29, 1045-1052 (2011).
5. Kazzaz J, Singh M, Ugozzoli M, Chesko J, Soenawan E, O'Hagan DT. Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency. J. Control. Release 110, 566-573 (2006). (Pubitemid 43168189)
6. Zhang ZP, Tongchusak S, Mizukami Y et al. Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery. Biomaterials 32, 3666-3678 (2011).
7. Cruz LJ, Tacken PJ, Fokkink R et al. Targeted PLGA nano-but not microparticles specifcally deliver antigen to human dendritic cells via DC-SIGN in vitro. J. Control. Release 144, 118-126 (2010).
8. Zindl CL, Chaplin DD. Tumor immune evasion. Science 328, 697-698 (2010).
9. Beaudette TT, Bachelder EM, Cohen JA et al. In vivo studies on the effect of co-encapsulation of CpG DNA and antigen in acid-degradable microparticle vaccines. Mol. Pharm. 6, 1160-1169 (2010).
10. Thomann JS, Heurtault B, Weidner S et al. Antitumor activity of liposomal ErbB2/HER2 epitope peptide-based vaccine constructs incorporating TLR agonists and mannose receptor targeting. Biomaterials 32, 4574-4583 (2011).
11. Mottram PL, Leong D, Crimeen-Irwin B et al. Type 1 and 2 immunity following vaccination is infuenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus. Mol. Pharm. 4, 73-84 (2007).
12. Win KY, Feng SS. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26, 2713-2722 (2005).
13. Kulkarni SA, Feng SS. Surface functionalized nanoparticles of biodegradable polymers for targeted delivery of diagnostic and therapeutic agents across the blood-brain barrier (BBB). Nanomedicine (Lond.) 6(2), 377-394 (2011).
14. Carstensa MG, Camps MGM, Henriksen-Lacey M et al. Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines. Vaccine 29(29-30), 4761-4770 (2011).
15. Mohanan D, Slütter B, Henriksen-Lacey M et al.Administration routes affect the quality of immune responses: a cross-sectional evaluation of particulate antigen-delivery systems. J. Control. Release 147, 342-349 (2010).
16. Herber DL, Cao W, Nefedova Y et al. Lipid accumulation and dendritic cell dysfunction in cancer. Nat. Med.16, 880-886 (2010).
17. Nochi T, Yuki Y, Takahashi H et al. Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. Nat. Mater. 9, 572-578 (2010).
18. DeMuth PC, Su Xf, Samuel RE, Hammond PT, Irvine DJ. Nano-layered microneedles for transcutaneous delivery of polymer nanoparticles and plasmid DNA. Adv. Mater. 22, 4851-4856 (2010).